Arc1p: Anchoring, routing, coordinating  by Frechin, Mathieu et al.
FEBS Letters 584 (2010) 427–433journal homepage: www.FEBSLetters .orgReview
Arc1p: Anchoring, routing, coordinating
Mathieu Frechin a, Daniel Kern a, Robert Pierre Martin b, Hubert Dominique Becker a,*, Bruno Senger a,*
aUPR 9002 ‘Architecture et Réactivité de l’ARN’, Université de Strasbourg, CNRS, Institut de Biologie Moléculaire et Cellulaire, 15 Rue René Descartes, F-67084 Strasbourg Cedex, France
bUMR 7156 ‘Génétique Moléculaire, Génomique, Microbiologie’, CNRS, Université de Strasbourg, Department of Molecular and Cellular Genetics,
21 Rue René Descartes, 67084 Strasbourg, France
a r t i c l e i n f o a b s t r a c tArticle history:
Received 29 September 2009
Revised 9 November 2009
Accepted 9 November 2009
Available online 13 November 2009
Edited by Michael Ibba
Keywords:
Dual localization
Aminoacylation
tRNA
Mitochondria
Metabolism
Saccharomyces cerevisiae0014-5793/$36.00  2009 Federation of European Bio
doi:10.1016/j.febslet.2009.11.037
* Corresponding authors. Fax: +33 (0) 3 88 60 22 1
E-mail addresses: h.becker@ibmc.u-strasbg.fr (H
u-strasbg.fr (B. Senger).Accurate synthesis of aminoacyl-tRNAs (aa-tRNA) by aminoacyl-tRNA synthetases (aaRS) is an abso-
lute requirement for errorless decoding of the genetic code and is studied since more than four dec-
ades. In all three kingdoms of life aaRSs are capable of assembling into multi-enzymatic complexes
that are held together by auxiliary non-enzymatic factors, but the role of such macromolecular
assemblies is still poorly understood. In the yeast Saccharomyces cerevisiae, Arc1p holds cytosolic
methionyl-tRNA synthetase (cMRS) and glutamyl-tRNA synthetase (cERS) together and plays an
important role in ﬁne tuning several cellular processes like aminoacylation, translation and carbon
source adaptation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In all living cells, protein synthesis represents an essential pro-
cess that can be considered to be at the heart of life. While in pro-
karyotes all the steps necessary for translation of the genetic
information occur in the same compartment, in eukaryotes, a lipid
bi-layer surrounding the genetic material physically separates the
site of transcription from that of translation. In eukaryotes there is
a higher degree of complexity in cellular organization combined to
higher gene content and to existence of compartmentalized gen-
omes. This complexity is further increased by the presence of mac-
romolecular assemblies or nanoparticles that cluster molecules
usually functioning as individual catalysts in prokaryotic path-
ways. The decoding ribosome is in need of a continuous supply
of aa-tRNAs that are produced by the attachment of the correct
amino acid to the corresponding isoaccepting tRNA by the cognate
aaRS. While in bacteria these enzymes are believed to mainly act as
standalones, in mammals nine aaRS activities and three auxiliary
non-catalytic factors (p43, p38 and p18) are engaged in a multi-
aminoacyl-tRNA synthetase (MARS) complex [1] presumably only
devoted to aa-tRNA production. Recently, such a MARS complexchemical Societies. Published by E
8.
.D. Becker), b.senger@ibmc.has also been found in archaea [2,3]. However, the exact role of
the MARS complex remains mysterious and it has been postulated
that it is an anchoring platform for aaRSs capable of performing
other tasks [4]. Indeed, throughout the years, it has become clear
that aaRSs are capable of multitasking depending on several
conditions, like their intracellular location or their association with
third parties molecules (reviewed in [5]). Thus, aaRSs are multi-
functional enzymes whose expanding repertoire of activities goes
far beyond aa-tRNA production.
In this review we will focus on the MARS prototype that can be
found in the yeast Saccharomyces cerevisiae and that is composed of
three proteins, two cytosolic aaRSs, cMRS and cERS, and one non-
enzymatic factor, Arc1p, a homologue of human p43 auxiliary pro-
tein of the MARS complex [6]. This complex has been proposed to
be dedicated to the production of aa-tRNAs in order to feed the
translating ribosome. In the latter process, tRNA is a key player
and has therefore been widely studied over the past four decades.
From these studies arose very early the concept of tRNA channel-
ling [7,8] supporting the idea that tRNA is handled over from one
factor to another from the nucleolus, where tRNA is synthesized,
to the cytoplasm, where tRNA is used in translation. Nevertheless,
little is known about the tRNA channelling process itself albeit
individual steps (transcription, modiﬁcation, 30 and 50 trimming,
splicing) of a tRNA lifecycle become more and more studied.
Among these, the nuclear exit of tRNA through the nuclear pore
complexes does not occur by simple diffusion although the sizelsevier B.V. All rights reserved.
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Overall, the study of tRNA dynamics has led to the discovery of sev-
eral factors important for tRNA trafﬁcking (reviewed in [9]), among
them Arc1p that will be analyzed in more details here.Fig. 1. Schematic view of Arc1p and its corresponding complex. Upper part: Arc1p
is composed of three distinct domains ranging from 1–131 (N-domain), 132–201
(M-domain) and 201–376 (C-domain). The biotinylation site at K86 is represented.
Lower part: drawing representing the full Arc1pcMRScERS complex together with
the cognate tRNAs.2. Arc1p, a protein linked to the tRNA life cycle
Nucleocytoplasmic exchanges represent crucial events during
the eukaryotic life cycle, and a lot of efforts have been made to
identify the constituents of nuclear pore complexes (NPC), espe-
cially in yeast. Starting from a thermosensitive (ts) allele of NSP1,
an essential component of the NPC [10], it has been shown that
combination of this mutation with another one lying in the LOS1
gene is lethal thus demonstrating the existence of a genetic link,
called synthetic lethality, between these two genes [11]. In other
words, the functions of Los1p and Nsp1p are somehow overlapping
or dependent on each other. At that time, LOS1 was believed to be
involved in tRNA biogenesis, since los1-1 mutants are accumulat-
ing unspliced tRNAs inside the nucleus [12]. Nearly two decades la-
ter, its function as a tRNA transporter belonging to the importin b
family of transport factors was deﬁnitively established [13]. Thus,
it is easy to understand the synthetic relationship between Los1p
and Nsp1p since the ﬁrst is implicated in tRNA transport and the
second is an essential member of the nuclear gate.
Subsequently, a second genetic screen searching for yeast
strains that exhibit a synthetic lethality relationship to a los1 null
mutant was performed [6]. The latter identiﬁed a gene that was
named ARC1 (aminoacyl-tRNA synthetase cofactor 1) and encod-
ing an overall basic protein (pI = 8.99) of 376 amino acids with a
predicted molecular weight of 42 kDa. Arc1p can be divided into
three domains (Fig. 1). First, a N-terminal domain (residues 1–
131) that was originally described with little or no homology to
known proteins. However, recently, the crystal structure of an N-
terminal fragment of Arc1p (residues 1–122) revealed that it can
adopt a GST-like fold [14]. Second, a central domain (residues
132–200) that is lysine-/alanine-rich and that displays sequence
similarity to histones. Finally, the C-terminal domain presents
homologies to human EMAPII (endothelial-monocyte-activating
polypeptide II). The ﬁrst half of this domain is also homologous
to the C-terminus of prokaryotic MRS and to a lesser extend to
the N-terminus of the b chain of phenylalanyl-tRNA synthetase.
In order to gain insight into Arc1p function, afﬁnity puriﬁcation
with protein A tagged-Arc1p brought two closely migrating bands
on SDS–PAGE. The analysis of the latter allowed identiﬁcation of
two cytosolic class I aaRSs, cMRS and cERS, therefore demonstrating
the existence of a small MARS-like complex, in yeast, that probably
represents an evolutionary intermediate towards larger aaRS com-
plexes [6]. The association of these enzymes with Arc1p enhances
their catalytic activities by several orders of magnitude [6,15,16].
Although no physical interaction between Los1p and Arc1p could
be detected, their functional link can be easily understood, thereby
explaining the synthetic lethality observed between the los1 null
mutant and an arc1mutant. Indeed, a defect in Los1p hinders tRNA
export and when combined to a mutation in Arc1p that probably
affects aa-tRNA production, the overall aa-tRNA production may
be too weak to sustain cell growth. Thus, Arc1p not only creates
a functional link between tRNA transport and aminoacylation but
also modulates the enzymatic activities of both, cERS and cMRS.3. Arc1p, a cofactor for cMRS and cERS
The ﬁnding that Arc1p can interact simultaneously with two
cytoplasmic aaRSs, cMRS and cERS, was intriguing since the exis-
tence, in yeast, of a complex resembling the mammalian MARS
complex had never been described before. cMRS and cERS areresponsible for the aminoacylation of their cognate tRNAs with
the corresponding amino acid and the advantage of such a multi-
synthetasic organization became an essential question to answer
and it was shown that the main purpose of this complex is to en-
hance the aminoacylation efﬁciency of both aaRSs for their cognate
tRNAs [6,16]. Indeed, in the case of cMRS, the overall catalytic efﬁ-
ciency is increased by two orders of magnitude with a major effect
on the Km [6]. For cERS, the overall efﬁciency is only stimulated by a
factor of 10 with a better tRNA-binding afﬁnity for the Arc1p-cERS
complex as compared to cERS alone [16]. Thus, Arc1p acts for both
enzymes as a tRNA-attracting molecule thereby enhancing tRNA
availability for these enzymes.
This tRNA-attracting capacity is explained by the speciﬁc struc-
tural organization of Arc1p. This protein is composed of three main
domains called N (1–131), M (132–200) and C (201–376) dedicated
respectively to protein–protein interaction (N) [17], non-speciﬁc
RNA binding (M) and speciﬁc tRNA-binding domain (C) [6,17];
M- and C-domains forming together the TRBD (tRNA-binding do-
main) of Arc1p. The N-terminal part of Arc1p (1–131) is responsi-
ble for Arc1pcMRScERS complex formation. This N domain
contains a Glutation-S transferase (GST)–like fold shared by the
N-terminus of Arc1p and the two aaRSs [14]. These GST-like folds
mediate strong interactions between the N-terminal part of both
aaRSs and Arc1p. The structure of Arc1p N-terminal domain
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distant but overlapping in the primary sequence [14,18,19]. The
Arc1pMetRS interaction resembles a classical GST homodimer
[14] and shows a dissociation constant (Kd) of 193 nM determined
by surface plasmon resonance [19]. Speciﬁc point mutations, based
on the crystallographic structure, show that Ala26 and Ser33 of
Arc1p are essential for the complex formation [19].
In contrast, cERS and Arc1p show a new type of interaction be-
tween two GST-like folds. These interactions are larger and may
be mediated by at least three important residues on Arc1p namely
Thr55, Arg100 and Tyr104 [19]. The related Kd is 53 nM indicating a
more stable interaction between cERS and Arc1p in accordancewith
the broader interaction surface as compared to the MetRSArc1p
interface [14]. Moreover, it is interesting to notice that the N-termi-
nus of each aaRS interacts more efﬁciently with Arc1p than the
whole enzyme, indicating that the catalytic core of cMRS and cERS
induces certain instability in the protein–protein interaction.
The TRBDwas deﬁned on the basis of Arc1p deletions and tRNA-
binding studies [17]. It is homologous to the mammalian protein
EMAPII and is dedicated to RNA binding when Arc1p is free. In fact,
early pull down and gel shift assays, coupled with gel ﬁltration
studies [6,17] showed that Arc1p alone is able to bind different
types of RNAs like 5S RNA (weak binding), and to a subset of tRNA
species [15]. However, when Arc1p is aaRS-bound, tRNA-binding
speciﬁcity of the complex becomes restricted to tRNAGlu and –Met
[6]. This tRNA-binding capacity is ensured by the TRBD of Arc1p
which is located both on the M (132–201) and C (201–376) do-
mains of Arc1p [6]), each of them showing a distinct function in
the RNA binding capacity of the TRBD domain. The M part is a ly-
sine/alanine-rich region similar in sequence to H1 histones. This
part of the TRBD is a general and non-speciﬁc RNA binding domain
[17] in which a high concentration of positive charges interacts
with the phosphate backbone of RNAs. The C part is a tRNA-speciﬁc
binding domain [17] displaying an OB fold architecture [18] that
can be found in many tRNA-binding domains like the mammalian
EMAPII or the bacterial trbp111 protein [20].
As mentioned above, when Arc1p is engaged in a complex with
cMRS and/or cERS, its speciﬁcity is restricted to tRNAGlu and –Met
binding. It seems that the TRBD of Arc1p works in tandem with
the anticodon binding domain of the two aaRSs which, usually in
aaRSs, is crucial for recognition and discrimination of the cognate
tRNA [21]. Arc1p TRBD not only reinforces the speciﬁcity of
aaRStRNA recognition but more importantly restricts binding of
each aaRS to its cognate tRNA [15]. Resolution of the 3D-structure
of the entire nanoparticle bound to the cognate tRNAs should give
us some insights into how Arc1p operates this speciﬁcity and efﬁ-
ciency enhancement for both aaRSs. The model proposed by Simos
and coworkers suggests that Arc1p stabilizes and delivers tRNAs to
the aaRSs, by acting like a molecular bridge [17]. By doing so, Arc1p
contributes to expose the two tRNAs in a conformation competent
for efﬁcient recognition by their cognate synthetase. This model
explains the tRNA afﬁnity enhancement for the two aaRSs but re-
quires that the tRNA is primarily captured by Arc1p prior transfer
onto cMRS and cERS. Thus, Arc1p may not loose its general RNA
binding capacity when complexed to cMRS and cERS [15].
One possibility would be that upon binding to Arc1p, cERS and
cMRS could mask only the non-speciﬁc RNA binding part of the
TRBD domain and, after initial RNA selection performed by cMRS
and cERS, Arc1p might stabilize the tRNA-aaRS interaction. It was
observed that during formation of the Arc1pMetRS complex the
TRBD and cMRS are brought close to each other. This can be repro-
duced artiﬁcially by fusing the Arc1p TRBD to the catalytic core of
cMRS (i.e. a N-terminally truncated cMRS). This chimeric protein
was shown to fulﬁl all the functions of a native Arc1pcMRS com-
plex [22], showing that the TRBD can readily be considered as a
functional module to enhance tRNA aminoacylation.This line of experiments raises a more general question: if the
TRBD is, like in bacteria, fully efﬁcient when fused to aaRSs, why
evolution has led to the transfer of this TRBD domain from aaRSs
to a trans-acting protein like Arc1p in higher organisms? One of
the possibility is that Arc1p plays other roles that require binding
to RNA and alternatively, for yet unforeseen reasons, both cMRS
and cERS individual tRNA-binding capacities have to be weakened.4. Arc1p, a cytosolic anchoring platform for aaRSs
The functional relationship between ARC1 and LOS1 points at
Arc1p being a cytosolic receptor for tRNAs before their delivery
to cMRS and cERS. Indeed, free Arc1p can bind a large variety of
tRNAs but binding becomes restricted to tRNAMet and tRNAGlu
upon recruitment of cMRS and cERS into the heterotrimeric particle
[15]. Thus, Arc1p might very likely be a key molecule of the ‘‘tRNA
channel” that is certainly more complex than initially thought. In-
deed, recent advances in the ﬁeld of tRNA trafﬁcking, has revealed
a lot of surprises ranging from intra-nuclear tRNA aminoacylation
to tRNA re-import inside the nucleus (reviewed in [9]). Overall,
these studies show that the nucleocytoplasmic trajectory of tRNA
is not unidirectional but can rather be bidirectional and that tRNA
uses multiple tracks for these exchanges. The direction and path-
way used for tRNA trafﬁcking turns out to probably be inﬂuenced
by multiple environmental conditions (nutrient availability, stress,
etc.).
In addition to Arc1p, a protein named Cex1p, a possible func-
tional homologue of Arc1p, has been shown to be involved in tRNA
channelling from the NPC to the translational machinery [23]. On
the nuclear side, another factor involved in tRNA trafﬁcking named
Utp8p is in charge of transferring tRNAs to the export receptors
[24]. Thus, proteins like Arc1p, Cex1p and Utp8p that are distrib-
uted along the tRNA route and control the tRNA trafﬁc could con-
stitute cellular key switches for regulating the whole translational
machinery. Indeed, although Arc1p is not an essential protein per
se, it plays a crucial role in adaptation of yeast to the change of
nutritional carbon source (see below).
Considering MARS complexes or the simpliﬁed yeast homo-
logue, the exact function of these aaRSs assemblies remains myste-
rious and their exact composition might still be matter of debate.
Indeed, one cannot exclude that in vivo they might contain more
aaRSs and that some are lost during the puriﬁcation procedure.
With regard to their function, a recent work has shown that argi-
nyl-tRNAArg (R-tRNAR) produced by an arginyl-tRNA synthetase
(RRS) sequestered in the MARS complex is a better substrate for
protein synthesis than the same R-tRNAR synthesized by free RRS
[25]. Nevertheless, this gives no extra clue concerning the role of
the MARS complex. An interesting possibility comes from the
growing number of atypical functions displayed by mammalian
aaRSs (reviewed in [26]). Indeed, when they are member of the
MARS complex, aaRSs are devoted to aa-tRNA production and,
upon release from MARS, some have be shown to exert alternate
roles suggesting that the MARS complex might be a retention plat-
form for regulatory multi-functional proteins ([4,27]). Such non-
conventional role has recently been unravelled for the bifunctional
glutamyl-prolyl-tRNA synthetase (EPRS) that is implicated in the
inﬂammatory response upon c-interferon treatment [28].
Although the multi-synthetase complex is smaller in yeast than
in higher eukaryotes, we have been able to show that, in this
organism, the particle composed of cERS, cMRS and Arc1p is also
able to be dissociated in order to allow the release of individual
components to fulﬁl other cellular tasks [29]. In yeast like in any
other eukaryote the gene encoding mitochondrial glutaminyl-tRNA
synthetase (mQRS) is always missing suggesting that, like in plants
[30,31] mitochondrial glutaminyl-tRNAGln (Q-mtRNAQ) synthesis is
Fig. 2. Models for the role of Arc1p during fermentation or respiration. Fermen-
tation panel (upper): When grown under fermentative conditions (e.g. on glucose
media); Arc1p is abundant and cERS is sequestered in the cytosol. Basal amounts are
maintained inside the mitochondria to ensure minimal organellar activity. Respi-
ration panel (lower): when grown under respiratory conditions, yeast cells are in
demand of high mitochondrial activity. Arc1p’s expression is repressed and allows
import of large amounts of cERS into the mitochondria to sustain the augmented
need of organellar translation. For clarity, cMRS is not represented here, but upon
Arc1p repression, free cMRS is believed to reach the nucleus.
430 M. Frechin et al. / FEBS Letters 584 (2010) 427–433achieved via the transamidation pathway. Further evidences for
the use of this pathway to form Q-mtRNAQ came from the identiﬁ-
cation of a yeast mitochondrial tRNA-dependent amidotransferase
(AdT) able to convert misacylated mitochondrial glutamyl-tRNAGln
(E-mtRNAQ) into Q-mtRNAQ. To our surprise while it had been
shown by us and others that mitochondrial ERS (mERS) is unable
to produce the misacylated E-mtRNAQ substrate for the AdT
[29,32], we could show that cytosolic ERS (cERS) is the mitochon-
drial non-discriminating ERS that supplies the AdT with its mis-
charged substrate. Under normal growth conditions, meaning
when yeast uses fermentation to produce energy, only basal levels
of mitochondrial activity are required and, therefore, most of the
cERS is sequestered by the Arc1pcMRScERS particle. However,
when yeast switches to the respiratory metabolism, we showed
that expression of Arc1p is drastically reduced leading to release
of both cMRS and cERS that are redirected respectively to the nu-
cleus and mitochondria (Fig. 2; [29]). In the case of cERS, its mito-
chondrial relocation can be easily understood since intense
respiration by yeast cells requires high levels of mitochondrial
activity and de facto translation. Thus, Arc1p, beside its function
as an aaRS catalytic enhancer, acts as a cytosolic anchoring plat-
form for cERS and probably, for cMRS since the disruption of its
interaction with Arc1p triggers its nuclear entry [19]. In fact, our
work suggests that yeast cERS should rather be considered as a
bona ﬁde mitochondrial enzyme that requires binding to Arc1p to
be kept in the cytoplasm. From these ﬁndings it is now clear that
Arc1p is a multi-functional factor and that its primary function,
in yeast, is to coordinate mitochondrial and cytosolic translation
levels in response to the switch in nutritional carbon source (for
a recent review on yeast metabolism adaptation see [33]).
The roles of the various domains of Arc1p have been elucidated
using an array of deletion mutants. Using this strategy it was
shown that the C-terminal domain of Arc1p or a partial N-termi-
nally truncated mutant of Arc1p, both unable to bind cMRS and
cERS, relocalize in the nucleus [18]. This means that Arc1p itself
might have the potential to enter into the nucleus. However, the
exact natural physiological conditions for which this nuclear relo-
cation might happen have not yet been deciphered. One could
imagine that, upon dissociation of the Arc1pcMRScERS particle,
triggered by a yet unidentiﬁed signal, each individual component
can reach the nucleus and could even reassemble inside the nu-
cleus, although the existence of the Arc1pcMRScERS particle in-
side the nucleus has never been shown. If, nonetheless, this
would be the case, the trimeric particle could serve, like any other
aaRS that has been shown to be localized inside the nucleus, to
proofread the integrity of matured tRNAs by aminoacylating them
prior to their nuclear export. Because of its genetic relationship
with Los1p, Arc1p is supposed to participate to the overall tRNA
export process by capturing tRNAs that come out from the NPC.
Its involvement in the nucleocytoplasmic export pathway of tRNA
might even be more intricate since it has been shown that Arc1p is
capable of actively shuttling between the nuclear and cytoplasmic
compartments [34]. In fact, when fused to a strong nuclear locali-
zation signal (NLS), Arc1p remains in the cytosol but when turning
off the Xpo1p export pathway (xpo1-1 mutant) Arc1p-GFP-NLS is
sequestered inside the nucleus. This ﬁnding could as well suggest
that the entire Arc1pcMRScERS complex might be capable of
shuttling between the nucleus and the cytoplasm although this
hypothesis has not been envisaged by Simos and his colleagues,
who alternatively showed that all individual components can do
so. As mentioned above, it is still unknown what could trigger (to-
tally or partially) dissociation of the cytosolic Arc1pcMRScERS
particle to allow nuclear relocation of the three proteins. It has
been shown that Arc1p can be biotinylated in vivo [35]. This
post-translational modiﬁcation could enable Arc1p shuttling and
facilitate free tRNA export. Indeed, amsn5D los1D strain is still ableto grow showing that at least a third route for tRNA export exists.
However, one must also keep in mind that dissociation of the par-
ticle will release cMRS and cERS in the cytoplasm and these en-
zymes will probably relocate to the nucleus and mitochondria
respectively. The remaining question is then: ‘‘why and to what ex-
tent” will these enzymes relocate and what will be their new func-
tion in the alternative subcellular compartment? Indeed, the cERS
level is drastically increased in the mitochondria of respirating
yeast cells while that of Arc1p goes the opposite way in the cyto-
plasm [29]. Upon nuclear relocation of cMRS, we speculate that this
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the mitochondrial relocation of cERS seems to be clearly under-
stood, that of its weak nuclear localization observed earlier [18] re-
mains unanswered. Overall, Arc1p is more than an aaRS cofactor
and it seems to occupy a strategic position at crossroads of several
biological pathways like aminoacylation, translation and carbon
source adaptation.
5. Arc1p a protein found in multiple cellular pathways
Although Arc1p is not encoded by an essential gene, it inter-
acts with essential ones and might inﬂuence or regulate their
activity, thus readily acting as a molecular coordinator of various
machineries (e.g. cytosolic vs. mitochondrial translation). We
have already seen that Arc1p plays an important role in aminoa-
cylation and most probably in tRNA export from the nucleus but
also in the adaptation of the cell during the switch from fermen-
tative to respiratory metabolism (Fig. 3). Identiﬁcation of Arc1p as
being a target of the biotin ligase Bpl1p, biotinylating Arc1p at
position Lys 86 is of particular interest [35]. Indeed, afﬁnity puri-
ﬁcation of biotinylated Arc1p from yeast reveals a single band on
SDS–PAGE thereby indicating that upon modiﬁcation Arc1p can
no longer bind to cMRS and cERS. Nevertheless, biotinylated or
not, no gain or loss of function was observed so far for Arc1p,
leaving the role of biotin attachment mysterious [35]. This is in
complete accordance with our model of functioning for Arc1p,
with respect to yeast metabolic adaptation, and we speculate that
biotinylation of Arc1p could be used to trigger the release of cERS
(and/or cMRS) when yeast cells switch from fermentation to res-
piration in order to provide a quick response for the need to en-
hance mitochondrial translation. Indeed, cERS that is sequestered
in the cytosol via its interaction with Arc1p may be a limiting
component of the mitochondrial translation apparatus. Thus, bio-
tinylation of Arc1p may be followed by repression of Arc1p pro-Fig. 3. Arc1p is at crossroads of many pathways. Arc1p can be subjected to phosphorylat
some or all individual components to reach the nucleus. Once there, it may bind to genom
role in tRNA export. Arc1p may inﬂuence the synthesis of ribosomes by having a potentia
the relocation of cERS and cMRS. Finally, the lipid binding capacity of Arc1p is representduction that could constitute a response for long-term
adaptation. More recently, it has been proposed that Arc1p may
be involved in a biotin sensing mechanism [36]. Overall, the ﬁnd-
ing that a protein like Arc1p can be biotinylated (Fig. 3) is some-
what surprising since the main targets of this modiﬁcation are
biotin-dependent enzymes used mainly for carboxylation and
decarboxylation reactions (reviewed in [37]).
Arc1p is a factor with protein and nucleic acid binding capaci-
ties that has also been identiﬁed for its ability to associate with
G-quadruplexes (G4) [38]. Although Arc1p was found in associa-
tion with cERS in these experiments, all biochemical proofs for
G4 binding were performed with free recombinant Arc1p suggest-
ing the idea that this property is due to Arc1p alone. G-quadruplex-
es are likely to be formed in regions that are G-rich and are thought
to be implicated in telomere maintenance, transcriptional regula-
tion and ribosome biogenesis (reviewed in [39]). These observa-
tions further imply that Arc1p is able to reach the nucleus in
order to bind such structures which are in agreement with the
ﬁndings described above and that show that Arc1p is able to enter
the nucleus. What would be the function or the consequence of
Arc1p binding to G-quadruplexes? Although these questions have
been raised [38], they remain, so far, unanswered.
Another possible nucleic acid interacting with either Arc1p or
cERS, is genomic DNA, since Arc1p and cERS have been found to
associate with apurinic/apyrimidic sites of damaged DNA [40]. It
is not clear if this interaction occurs when both proteins form a
complex or if each of them has this capacity. The authors of this
work have shown it for cERS and we can only speculate about such
a binding for Arc1p. Nevertheless, it is plausible for Arc1p too,
considering that it possesses a general nucleic acid binding do-
main. Altogether, these data again reinforce the possibility that
both Arc1p and cERS can enter the nucleus to exert a function that
is unrelated to protein synthesis, thereby increasing their func-
tional repertoire. It is tempting to speculate that cERS would alsoion or biotinylation. This may trigger its dissociation from cERS and cMRS and allow
ic DNA lesions (as could cERS upon import inside the mitochondria) in addition to a
l role as a chaperone. The carbon source – regulated expression of Arc1p also allows
ed.
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mitochondria.
Among the molecules able to bind Arc1p are phospholipids [41]
that are constituents of the membranes delimiting cellular com-
partments or entire cells. Moreover, phospholipids are also known
to act as signalling molecules or to modulate the activity of mem-
brane-bound proteins. Therefore, alteration in lipid composition of
membranes may inﬂuence numerous cellular processes. How is
Arc1p connected to phospholipids and how could it inﬂuence other
cellular pathways is largely unknown.
Such observations also denote the complexity of the intercon-
nections that exist between different cellular pathways. Indeed,
sterol biosynthesis and isopentenylation of adenines within tRNAs
use a common intermediate, dimethylallyl pyrophosphate, there-
fore linking a key player of translation to sterol metabolism. It
has been shown that disrupting the balance in the enzymes that
use dimethylallyl pyrophosphate by altering the intracellular dis-
tribution of Mod5p, the enzyme that catalyzes the synthesis of
i6A in tRNAs, affects translation by inﬂuencing non-sense suppres-
sion activity of tRNAs. In a search for suppressors of such a pheno-
type, Arc1p was selected as a candidate [42]. However, no clear
answer could be found with regard to a potential role of Arc1p.
Finally, Arc1p has also been identiﬁed in a screen looking for
suppressors of subunits of the Cct chaperonin complex that is in-
volved in folding various proteins including ribosomal proteins
[43]. Although Arc1p does not seem to have any chaperone activ-
ity, it interacts with several components of the translational
machinery leaving it conceivable that it could palliate a slight de-
fect of some of them. Another, yet unclear, implication of Arc1p
would be in the mitotic exit network since Arc1p has been found
as a potential target of the Dbf2-MobI kinase complex [44]. Could
this mean that Arc1p might be involved in tuning translational
activity when cells divide?6. Concluding remarks
Since its initial discovery 14 years ago as a G-quadruplexes-
binding protein, the proposed functional repertoire of Arc1p has
signiﬁcantly expanded mainly during the past ﬁve years (Fig. 3).
Nevertheless, its ability to bind simultaneously cMRS and cERS to
form a mini-MARS complex is a major ﬁnding for the elucidation
of some of its functions. Moreover, the genetic interaction with
LOS1 combined to its general tRNA-binding capacity creates a di-
rect link between tRNA export and aminoacylation. When, at the
beginning of this millennium, it became clear that aminoacylation
can take place inside the nucleus, the intracellular location of the
individual components has been more carefully investigated show-
ing that they are more dynamic than initially thought, although
most of the alternate locations observed are poorly understood at
the functional level. However, it became clear that Arc1p consti-
tutes a cytosolic retention platform for cMRS and cERS that is itself
regulated as a function of the carbohydrate used by the yeast cell
to produce energy. This creates an unexpected but very important
link between metabolism and protein synthesis since it allows to
coordinate both the cytoplasmic and organellar translational
machineries.
Arc1p can be subjected to post-translational modiﬁcations like
biotinylation and/or phosphorylation therefore placing it at cross-
roads of various cellular paths. Having its dynamic localization in
mind, it is plausible that various partners of Arc1p may be selected
upon a given type of post-translational modiﬁcation and that intra-
cellular relocation of Arc1p then participates in the expression of
some of its alternate functions. Thus, our knowledge concerning
Arc1p may only represent the tip of the iceberg and underlines
the fact nowadays integrated biological approaches are absolutelyrequired to get a clear and complete picture of a protein’s func-
tion(s). This may lead to a better understanding of how several
molecular circuits are interconnected and will allow the emer-
gence of a complete view, at the molecular level, of the networks
governing a cell’s life cycle.
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